Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
medical tags : Treatment save search
APYX MEDICAL CORPORATION SHOWCASES NEW DATA AND TREATMENT INSIGHTS AT THE RENUVION USERS’ SUMMIT
Published: 2024-04-11 (Crawled : 12:00) - apyxmedical.com
FNCTF | News | $11.0354 -0.83% -20.84% 34K
|
Communications
|
| O: -100.0%
H: NaN%
C: Infinity%
APYX | $1.32 -5.04% -5.7% 79K
|
Health Technology
|
| O: 2.8%
H: 5.44%
C: 5.44%
renuvion corporation treatment medical apyx
AngioDynamics Receives 510(k) Clearance for AlphaVac F1885 System in Treatment of PE
Published: 2024-04-04 (Crawled : 12:00) - biospace.com/
ANGO | $6.33 -2.77% -2.84% 490K
|
Health Technology
|
| O: 1.43%
H: 12.5%
C: 0.0%
treatment clearance system
China's National Medical Products Administration Accepts Astellas and Pfizer's Supplemental Biologics License Application for enfortumab vedotin with KEYTRUDA® (pembrolizumab) for First-Line Treatment of Advanced Bladder Cancer
Published: 2024-03-28 (Crawled : 15:00) - prnewswire.com
ALPMY | News | $9.46 1.29% -1.11% 500K
|
Manufacturing
|
| O: 0.82%
H: 0.0%
C: -2.54%
keytruda license bladder cancer treatment medical application advanced
SAB Biotherapeutics Announces Clinical Partnership with Naval Medical Research Center to Advance Potential Influenza Treatment
Published: 2024-03-25 (Crawled : 14:00) - globenewswire.com
SABS | $4.6 -5.74% -6.09% 3.6K
|
|
| O: 1.43%
H: 0.0%
C: -14.14%
partnership influenza treatment research medical potential
Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea
Published: 2024-03-18 (Crawled : 12:30) - globenewswire.com
DERM | $3.86 1.58% 1.3% 130K
|
|
| O: 2.94%
H: 14.57%
C: 6.86%
FBIO | $1.77 0.57% 1.68% 250K
|
Health Technology
|
| O: 3.36%
H: 0.5%
C: -4.0%
dfd-29 fda drug corporation treatment medical application
XHANCE Approved by FDA as First and Only Medication Indicated for Treatment of Adults with Chronic Rhinosinusitis without Nasal Polyps
Published: 2024-03-15 (Crawled : 20:00) - globenewswire.com
OPTN | $1.02 -6.42% -6.86% 430K
|
Health Services
| Email alert
Add to watchlist
fda first xhance approved treatment
IceCure's ProSense® a Promising Alternative Treatment for Extra-Pelvis Endometriosis: Independent Study Presented at ECR 2024
Published: 2024-03-04 (Crawled : 15:00) - biospace.com/
ICCM | $1.29 -0.77% -0.39% 1.5M
|
Manufacturing
| Email alert
Add to watchlist
prosense treatment alternative study
Helius Medical Technologies, Inc. Announces Alignment with FDA on Registrational Program for Treatment of Stroke Patients
Published: 2024-02-06 (Crawled : 12:00) - globenewswire.com
HSDT | $5.18 -2.63% -2.9% 16K
|
Health Technology
|
| O: 25.39%
H: 7.47%
C: -27.04%
fda stroke treatment medical program
Lyme Disease Treatment Market is Expected to Showcase Significant Growth by 2032, Assesses DelveInsight | Key Companies - Pfizer, ModernaTX, Tarsus Pharmaceuticals, Valneva, Cortene
Published: 2024-01-15 (Crawled : 22:00) - prnewswire.com
DERM | $3.86 1.58% 1.3% 130K
|
|
| O: 1.45%
H: 8.38%
C: 6.95%
VYNE | $2.4 -0.83% -0.41% 31K
|
Health Technology
|
| O: 0.0%
H: 2.08%
C: -1.46%
TARS | $34.42 -1.38% -1.34% 330K
|
Health Technology
|
| O: 0.14%
H: 2.58%
C: 2.17%
disease companies expected treatment key growth market
Global Cellulite Treatment Market Size, Share & Trends Analysis Report 2023-2030 Featuring Leading Players - Merz Pharma, Hologic, Syneron Medical, Zimmer Aesthetics, Alma Lasers, Cymedics, and Nubway
Published: 2024-01-10 (Crawled : 19:00) - prnewswire.com
HOLX | $74.92 -0.25% -0.27% 1.3M
|
Health Technology
|
| O: -0.01%
H: 0.95%
C: 0.85%
report treatment global trends market
Nalu Medical, Inc. Announces $65 Million Equity Financing to Advance Treatment for Chronic Neuropathic Pain
Published: 2024-01-03 (Crawled : 17:00) - biospace.com/
NVO | News | $124.53 0.88% 0.19% 2.5M
|
Health Technology
|
| O: -0.06%
H: 1.75%
C: 1.54%
million treatment
RetinalGeniX™ Technologies Inc. Contracts With MEDsan, Inc. to Provide Diagnostic Testing Services for Its Institutional Review Board to Conduct a Study to Personalize Medical Evaluations for Patients Receiving Treatment for Wet Macular Degeneration
Published: 2023-12-26 (Crawled : 18:00) - globenewswire.com
RTGN | $3.09 203.88% 400
|
n/a
| Email alert
Add to watchlist
services macular diagnostic review treatment medical study
Data Published by Cureus Journal of Medical Science Shows Successful Treatment of Obstructive Sleep Apnea with ProSomnus Precision Oral Appliance Devices
Published: 2023-12-19 (Crawled : 13:00) - globenewswire.com
OSA | $0.5 -4.56% -4.78% 59K
|
n/a
|
| O: 39.34%
H: 55.32%
C: 13.15%
treatment prosomnus medical
Coherus and Junshi Biosciences Announce Publication of Positive Final Overall Survival Results of JUPITER-02, a Phase 3 Trial Evaluating LOQTORZI™ (toripalimab-tpzi) as Treatment for Nasopharyngeal Carcinoma, in the Journal of the American Medical Association
Published: 2023-11-28 (Crawled : 16:00) - globenewswire.com
CHRS | $2.15 0.0% 1.1M
|
Health Technology
|
| O: -1.55%
H: 12.83%
C: 10.47%
piter-02 association positive publication treatment medical trial results
Alpha Tau Announces Highly Promising Interim Results from Safety and Feasibility Trial of Alpha DaRT Treatment of Advanced Pancreatic Cancer
Published: 2023-11-28 (Crawled : 14:00) - globenewswire.com
DRTS | $2.69 -1.61% -1.26% 55K
|
n/a
|
| O: -0.33%
H: 7.21%
C: 5.25%
cancer pancreatic treatment tau trial dart results
Nutraceuticals Market to grow by USD 223.56 billion from 2022 to 2027 | The increasing cost of medical treatment to drive market growth - Technavio
Published: 2023-11-24 (Crawled : 10:00) - prnewswire.com
WMT | $59.65 -0.32% 0.17% 12M
|
Retail Trade
|
| O: 0.31%
H: 0.63%
C: 0.59%
ABT | News | $105.9 -3.03% 0.38% 11M
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
treatment medical growth market
FDA Approves Lilly's Zepbound™ (tirzepatide) for Chronic Weight Management, a Powerful New Option for the Treatment of Obesity or Overweight with Weight-Related Medical Problems
Published: 2023-11-08 (Crawled : 21:00) - biospace.com/
LLY | News | $750.77 0.54% 0.22% 2.8M
|
Health Technology
|
| O: 1.29%
H: 3.0%
C: 1.89%
fda obesity treatment medical tirzepatide
Rakuten Medical Presents AI-based Study in Two Posters on Immune Characteristics in Responders and Cellular Level Drug Quantification of Alluminox Treatment (Photoimmunotherapy) at SITC 2023
Published: 2023-11-06 (Crawled : 23:00) - prnewswire.com
RKUNY | $5.235 -0.48% 1.45% 42K
|
Retail Trade
|
| O: 0.27%
H: 0.81%
C: -0.54%
drug treatment medical study
RetinalGeniX IRB Approved to Conduct Study to Personalize Medical Evaluations for Patients Receiving Treatment for Wet Macular Degeneration
Published: 2023-10-30 (Crawled : 19:00) - globenewswire.com
RTGN | $3.09 203.88% 400
|
n/a
| Email alert
Add to watchlist
macular approved treatment medical study
Encouraging Preliminary Data from a Phase 2 Trial Evaluating IO102-IO103 in Combination with Pembrolizumab for First-line Treatment of Patients with Non-small Cell Lung Cancer and Squamous Cell Carcinoma of the Head and Neck Presented at the European Society for Medical Oncology (ESMO) Congress
Published: 2023-10-23 (Crawled : 05:00) - globenewswire.com
IOBT | $1.5 -0.66% 1.95% 37K
|
|
| O: -3.14%
H: 5.24%
C: -1.97%
io102 lung congress cancer cell treatment medical trial
Gainers vs Losers
| 57% | 43% |
Top 10 Gainers
INVO | $1.82 139.47% 56.82% 220M
|
Health Technology
SINT | $0.0373 62.88% 37.26% 460M
|
Health Technology
WISA 4 | $9.25 51.64% 34.27% 64M
|
Electronic Technology
EDBL | News | $6.66 46.37% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 600K
|
Manufacturing
TCON | $2.29 33.92% 26.61% 1.8M
|
Health Technology
TIRX | $0.4848 7.49% 24.58% 5.9M
|
SRFM 4 | $0.3859 -12.3% 23.84% 660K
|
n/a
KZIA | $0.3442 18.28% 23.42% 290K
|
Health Technology
CTM | $0.2201 -2.31% 22.67% 48K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.